MKS Instruments, Inc. (NASDAQ:MKSI) is a leading global provider of instruments, subsystems, and process control solutions essential for advanced manufacturing processes across various industries, including semiconductor, industrial technologies, life and health sciences, and research and defense. Competing with giants like Applied Materials and Lam Research in the semiconductor equipment sector, MKS Instruments has carved out a significant niche for itself.
On October 13, 2025, Morgan Stanley upgraded its rating for MKSI to "Overweight," signaling a positive outlook on the stock. This upgrade came with a significant price target increase from $120 to $151, reflecting Morgan Stanley's confidence in the stock's growth potential. At the time of the upgrade, MKSI was trading at approximately $130.18, and the recommendation was to hold, suggesting that investors should maintain their current positions in the stock.
Recently, MKSI has shown impressive momentum, with a price increase of 13.18% over the past week. This surge has caught the attention of momentum investors, who seek out stocks showing strong upward trends. MKS Instruments boasts a Momentum Style Score of B, according to Zacks Investment Research, indicating robust performance in this investing category.
The stock's current price stands at $133.01, marking an increase of 9.69% or $11.75. Throughout the trading day, MKSI has seen fluctuations between a low of $127.77 and a high of $133.18. Over the past year, the stock has experienced a high of $142.20 and a low of $54.84. With a market capitalization of approximately $8.93 billion and a trading volume of 397,954 shares on the NASDAQ exchange, MKS Instruments continues to be a significant player in its industry.
